- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03944343
Prebiotic Effects on Glucose Tolerance
June 24, 2020 updated by: Anne Nilsson, Lund University
Validation of a New Antidiabetic Food Concept Based on the Modulation of the Intestinal Flora
The primary purpose of this project is to evaluate effects in healthy humans on glucose tolerance of cereal products with high amounts of fermentable dietary fibre.
Secondary issues are to investigate effects of the test foods on subjective appetite variables, mood variables and gut microbiota composition.
The test food products will be consumed in the evening and test variables will be determined the next morning.
The study will apply a randomized crossover study design.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lund, Sweden, 22100
- Lund University, Food Technology, Engineering and Nutrition
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI 18.5 - 25 kg/m2
- age 20-40 years
- normal diet
- healthy
Exclusion Criteria:
- fasting blood glucose >6.1
- diagnosed or known disease
- known gastrointestinal disorder
- food allergies or intolerance
- special diet regiments
- smokers
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Reference product
Commercial cereals and a commercial yogurt
|
The cereal products are made from common Swedish cereals.
|
|
Experimental: Test product A
Specific designed cereals A and yogurt
|
The cereal products are made from common Swedish cereals.
|
|
Experimental: Test product B
Specific designed cereals B and yogurt
|
The cereal products are made from common Swedish cereals.
|
|
Experimental: Test product C
Specific designed cereals C and yogurt
|
The cereal products are made from common Swedish cereals.
|
|
Experimental: Test product D
Specific designed cereals D and yogurt
|
The cereal products are made from common Swedish cereals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glucose tolerance
Time Frame: 3 hours
|
The incremental (3 hours) blood glucose area under the curve after a standardized breakfast, following consumption of the test- or reference products the previous evening.
Glucose concentrations will be analysed from capillary blood at fasting and at 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, 150 min and 180 min after the standardized breakfast.
|
3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective appetite variables
Time Frame: 3 hours
|
Determination of appetite variables (satiety, hunger and desire to eat) at fasting in the morning and after the standardized breakfast following consumption of the test- or reference products the previous evening.
The appetite sensations will be determined at fasting and then at 30 min, 60 min, 90 min, 120 min, 150 min and at 180 min.
The variables will be determined by registration on a 0-100 mm visual analogue scales (VAS).
Higher ratings are considered to be better for the rating of satiety meanwhile lower ratings are considered to be better for hunger and desire to eat.
|
3 hours
|
|
Mood parameters
Time Frame: 3 hours
|
Determination of mood variables (activity and valence) at fasting in the morning and after the andardized breakfast, following consumption of the test- or reference products the previous evening.
The mood variables will be determined at fasting and then at 60 min, 120 min and at 180 min.
The variables will be determined by registration on a 0-100 mm visual analogue scales (VAS).
|
3 hours
|
|
Breath hydrogen
Time Frame: 3 hours
|
Determination of breath hydrogen concentrations will be performed at fasting and after the standardized breakfast, following consumption of the test- or reference products the previous evening.
Breath hydrogen will be determined at fasting and then at 30 min, 60 min, 90 min, 120 min, 150 min and at 180 min.
Breath hydrogen will be measured by exhaling in a portable measuring device.
|
3 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Anne Nilsson, associate professor, Lund University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 15, 2019
Primary Completion (Actual)
June 15, 2020
Study Completion (Actual)
June 24, 2020
Study Registration Dates
First Submitted
May 8, 2019
First Submitted That Met QC Criteria
May 8, 2019
First Posted (Actual)
May 9, 2019
Study Record Updates
Last Update Posted (Actual)
June 25, 2020
Last Update Submitted That Met QC Criteria
June 24, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018/1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diet Prevention of Metabolic Diseases
-
New York UniversityNot yet recruitingPre-diabetes | Lifestyle Risk Reduction | Diet Prevention of Metabolic DiseasesUnited Arab Emirates
-
San Diego State UniversityNational Cancer Institute (NCI)Completed
-
William Paterson University of New JerseyCompletedDiet Modification | Cancer Prevention | Vegetable IntakeUnited States
-
Claremont Graduate UniversityCompletedObesity | Diet | Obesity Prevention | Adolescents | Behavioral Intervention
-
King's College LondonDIANA FoodCompletedPrevention of HyperglycaemiaUnited Kingdom
-
National Research Center for Preventive MedicineThe League of Clinical Research, RussiaCompleted
-
Universidade do PortoCentro Hospitalar Universitário de São João, E.P.E.; Centro de Investigação... and other collaboratorsRecruitingNutritional Status | Diet, Vegetarian | Diet, Vegan | Metabolic ProfilePortugal
-
Arkansas Children's Hospital Research InstituteCompletedEffect of Diet on Breast Milk CompositionUnited States
-
Northwestern UniversityAgency for Healthcare Research and Quality (AHRQ)CompletedCardiovascular Diseases | Lipid Testing | Primary Prevention of Cardiovascular DiseaseUnited States
-
Assistance Publique Hopitaux De MarseilleRecruitingInherited Metabolic Diseases Requiring Restrictive and Specific DietFrance
Clinical Trials on Cereal based products
-
Chalmers University of TechnologyCompletedObesity | OverweightSweden
-
Pennington Biomedical Research CenterPepsiCo Global R&D; Quaker Oats CompanyCompletedFood Intake | SatietyUnited States
-
Frank GreenwayPepsiCo Global R&D; Quaker Oats CompanyCompletedFood Intake | SatietyUnited States
-
Mondelēz International, Inc.Centre de Recherche en Nutrition Humaine Rhone-Alpe; Institut de Recherches... and other collaboratorsCompletedBlood Glucose KineticsCanada
-
University College CorkRecruitingMetabolic Diseases, Type 2 Diabetes, Cardiovascular DiseaseIreland
-
USDA, Western Human Nutrition Research CenterAlmond Board of CaliforniaTerminated
-
Laboratorios OrdesaMinisterio de Ciencia e Innovación, SpainUnknownGastrointestinal Disorder | Immunologic Diseases in ChildrenSpain
-
University of GuelphBunge Global Innovation IncorporatedCompletedHyperglycemia | Lack of SatietyCanada
-
Harokopio UniversityNational and Kapodistrian University of AthensCompletedOverweight and ObesityGreece
-
Göteborg UniversitySahlgrenska University HospitalCompletedArthritis, Rheumatoid | Inflammatory Response | Diet, Healthy | Dietary ExposureSweden